Investing First patient dosed in Phase IIb imaging for Brain Mets by April 28, 2025 written by April 28, 2025 Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 comment 0 FacebookTwitterPinterestEmail previous post Binding Commitments Received for A$1.0 Million under Convertible Note Placement next post S&P 500 Rises from Bearish to Neutral, But Will It Last? Related Articles Copper Soars to All-time High as Trump Unveils... July 10, 2025 Apollo Silver; Right Assets, Right Management and Right... July 10, 2025 Cartier Unveils VRIFY-Generated AI Model Highlighting Key Discovery... July 10, 2025 Silver47 Conducts Prospecting and Soil Geochemical Surveys at... July 10, 2025 Kobo Resources Confirms Additional High-Grade Gold Mineralization at... July 10, 2025 Juggernaut Closes $1,100,000 from Institutions and Accredited Investors July 9, 2025 High Grade Cu-Au at Surface Delivers New Targets... July 9, 2025 Strong Leach Recoveries and Low Impurities July 9, 2025 Share Purchase Plan Offer Booklet July 9, 2025 Brunswick Exploration Has Now Identified Four Major New... July 9, 2025